Evidence map›Paper›PMID 21883167›Full record

ArticleClinical genetics2011

Development and validation of an instrument to measure the impact of genetic testing on self-concept in Lynch syndrome.

M J Esplen, N Stuckless, S Gallinger, M Aronson, H Rothenmund, K Semotiuk, J Stokes, C Way, J Green, K Butler and 2 more

Open access · greenAbstract readValidation Study
In one paragraph

Article in Clinical genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Sense of coherence and self-concept in Lynch syndrome.Hereditary cancer in clinical practice · 2013
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

M J EsplenBehavioral Sciences and Health Research Division, Toronto General Research Institute, University Health Network, Toronto, Canada. mesplen@uhnres.utoronto.ca
N Stuckless
S Gallinger
M Aronson
H Rothenmund
K Semotiuk
J Stokes
C Way
J Green
K Butler
H V Petersen
J Wong
Mount Sinai Hospital · CAMemorial University of Newfoundland · CAUniversity of Toronto · CAHvidovre Hospital · DKUniversity Health Network · CAYork University · CA

Funding

ONTARIO REGISTRY FOR STUDIES OF FAMILIAL COLON CANCERU01CA074783 · NCI · CANCER CARE ONTARIO · PI GALLINGER, STEVEN · 1997 to 2008
$12.5M
The Colon Cancer Family Registry: OntarioU24CA074783 · NCI · CANCER CARE ONTARIO · PI GALLINGER, STEVEN · 2008 to 2011
$4.1M
Redox Regulation of Metastasis by Sod2K22CA095011 · NCI · ALBANY MEDICAL COLLEGE · PI MELENDEZ, JUAN ANDRES · 2002 to 2004
$446k
CIHR CRT-43821CIHR FRN-79845NCI NIH HHS CA-95-011NCI NIH HHS U01 CA074783NCI NIH HHS U24 CA074783
6 · The paper itself

Abstract

A positive genetic test result may impact on a person's self-concept and affect quality of life. The purpose of the study was to develop a self-concept scale to measure such impact for individuals carrying mutations for a heritable colorectal cancer Lynch syndrome (LS). Two distinct phases were involved: Phase 1 generated specific colorectal self-concept candidate scale items from interviews with eight LS carriers and five genetic counselors, which were added to a previously developed self-concept scale for BRCA1/2 mutation carriers, Phase II had 115 LS carriers complete the candidate scale and a battery of validating measures. A 20-item scale was developed with two dimensions identified through factor analysis: stigma/vulnerability and bowel symptom-related anxiety. The scale showed excellent reliability (Cronbach's α = 0.93), good convergent validity by a high correlation with impact of event scale (r(102) = 0.55, p < 0.001) and Rosenberg self-esteem scale (r(108) = -0.59, p < 0.001), and a low correlation with the Fear questionnaire (r(108) = 0.37, p < 0.001). The scale's performance was stable across participant characteristics. This new scale for measuring self-concept has potential to be used as a clinical tool and as a measure for future studies.

Indexed as

Self ConceptAdultAgedAged, 80 and overAnxietyColorectal Neoplasms, Hereditary NonpolyposisFemaleGenetic TestingHeterozygoteHumansMaleMiddle AgedPsychological TestsReproducibility of ResultsSurveys and Questionnaires

Identifiers

PMID21883167
PMCPMC3237954
OpenAlexW2142575697

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.